150 related articles for article (PubMed ID: 11865085)
1. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.
Martinez MC; Nortier J; Vereerstraeten P; Vanherweghem JL
Nephrol Dial Transplant; 2002 Mar; 17(3):408-12. PubMed ID: 11865085
[TBL] [Abstract][Full Text] [Related]
2. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
[TBL] [Abstract][Full Text] [Related]
3. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
Nortier JL; Vanherweghem JL
Toxicology; 2002 Dec; 181-182():577-80. PubMed ID: 12505369
[TBL] [Abstract][Full Text] [Related]
4. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.
Lai MN; Lai JN; Chen PC; Hsieh SC; Hu FC; Wang JD
Am J Kidney Dis; 2010 Mar; 55(3):507-18. PubMed ID: 20116155
[TBL] [Abstract][Full Text] [Related]
5. Belgian (Chinese herb) nephropathy: why?
Violon C
J Pharm Belg; 1997; 52(1):7-27. PubMed ID: 9090927
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between two "fang ji" herbal medicines, Stephania tetrandra and the nephrotoxic Aristolochia fangchi, using hyperspectral imaging.
Tankeu S; Vermaak I; Chen W; Sandasi M; Viljoen A
Phytochemistry; 2016 Feb; 122():213-222. PubMed ID: 26632529
[TBL] [Abstract][Full Text] [Related]
7. [A new form of nephropathy secondary to the absorption of Chinese herbs].
Vanherweghem JL
Bull Mem Acad R Med Belg; 1994; 149(1-2):128-35; discussion 135-40. PubMed ID: 7841923
[TBL] [Abstract][Full Text] [Related]
8. [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)].
Nortier J
Nephrologie; 2002; 23(1):37-8. PubMed ID: 11908479
[No Abstract] [Full Text] [Related]
9. [End-stage renal insufficiency associated with Chinese herbal consumption in France].
Stengel B; Jones E
Nephrologie; 1998; 19(1):15-20. PubMed ID: 9551447
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
Unger P; Nortier J; Muniz Martinez MC; Plein D; Vandenbossche JL; Vereerstraeten P; Vanherweghem JL
Nephrol Dial Transplant; 2003 May; 18(5):906-10. PubMed ID: 12686663
[TBL] [Abstract][Full Text] [Related]
11. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.
Debelle FD; Nortier JL; De Prez EG; Garbar CH; Vienne AR; Salmon IJ; Deschodt-Lanckman MM; Vanherweghem JL
J Am Soc Nephrol; 2002 Feb; 13(2):431-436. PubMed ID: 11805172
[TBL] [Abstract][Full Text] [Related]
12. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.
Van Ypersele De Strihou C; Jadoul M
Nephrol Dial Transplant; 2002 Oct; 17(10):1852; author reply 1852. PubMed ID: 12271001
[No Abstract] [Full Text] [Related]
13. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy).
Vanherweghem LJ
J Altern Complement Med; 1998; 4(1):9-13. PubMed ID: 9553830
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study on metabonomics and on liver and kidney toxicity of Aristolochia fangchi and Stephania tetrandra].
Liang Q; Ni C; Yan X; Xie M; Zhang Y; Zhang Q; Yang M; Peng S; Zhang Y
Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2882-8. PubMed ID: 21322952
[TBL] [Abstract][Full Text] [Related]
15. [Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases].
Yu Y; Zheng FL; Li H
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):110-2. PubMed ID: 12783708
[TBL] [Abstract][Full Text] [Related]
16. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens.
Ioset JR; Raoelison GE; Hostettmann K
Food Chem Toxicol; 2003 Jan; 41(1):29-36. PubMed ID: 12453725
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid.
Wu F; Wang T
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):812-20. PubMed ID: 23462915
[TBL] [Abstract][Full Text] [Related]
18. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid.
Lai MN; Lai JN; Chen PC; Tseng WL; Chen YY; Hwang JS; Wang JD
Nephrology (Carlton); 2009 Apr; 14(2):227-34. PubMed ID: 19076288
[TBL] [Abstract][Full Text] [Related]
19. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?
Tanaka A; Nishida R; Maeda K; Sugawara A; Kuwahara T
Clin Nephrol; 2000 Apr; 53(4):301-6. PubMed ID: 10809420
[TBL] [Abstract][Full Text] [Related]
20. Aristolochic acid nephropathy: a worldwide problem.
Debelle FD; Vanherweghem JL; Nortier JL
Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
